ImmunGene Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4
  • Investments
  • 1

ImmunGene General Information

Description

Developer of therapeutic drugs designed to treat cancer, autoimmune creating disorders and other diseases. The company's therapeutic drugs are next generation of monoclonal antibody-based therapeutics, enabling healthcare institutions to avail drugs which primary focus on safe and effective treatments for cancer and serious diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 480 Constitution Avenue
  • Camarillo, CA 93012
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunGene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ImmunGene‘s full profile, request access.

Request a free trial

ImmunGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapeutic drugs designed to treat cancer, autoimmune creating disorders and other diseases. The company's
Drug Discovery
Camarillo, CA
000
000000&0 000

0000000

scing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veni
0000000000000
Beijing, China
00000
00000000

0000 000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmunGene Competitors (75)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Beijing Mabworks Biotech Venture Capital-Backed Beijing, China 00000 00000000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
00 000000000000 Venture Capital-Backed Guilford, CT 00 0000 000000000 - 0000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 75 competitors. Get the full list »

ImmunGene Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ImmunGene‘s full profile, request access.

Request a free trial

ImmunGene Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 13-Nov-2012 00000 0000000 Biotechnology 000000 00000 00.0
To view ImmunGene’s complete investments history, request access »

ImmunGene Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 13-Nov-2012 00000 0000000 Completed
  • 2 buyers
To view ImmunGene’s complete exits history, request access »